References
- BensadounR-JDaoudJEl GueddariBComparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasisCancer2008112120421118044772
- MendesAISilvaACCatitaJAMiconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activityColloids Surf B Biointerfaces201311175576323954816
- PedersenMEdelstenMNielsenVFFormation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazoleInt J Pharm1993903247254
- JainSJainSKharePDesign and development of solid lipid nanoparticles for topical delivery of an anti-fungal agentDrug Deliv201017644345120486871
- FothergillAWMiconazole: a historical perspectiveExpert Rev Anti Infect Ther20064217117516597199
- van den BosscheHBiochemical effects of miconazole on fungi – I: effects on the uptake and/or utilization of purines, pyrimidines, nucleosides, amino acids and glucose by Candida albicansBiochem Pharmacol19742348878994596244
- NafeeNAIsmailFABoraieNAMucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageingInt J Pharm20032641211412972331
- TsutsumiSIidaMTadaNCharacterization and evaluation of miconazole salts and cocrystals for improved physicochemical propertiesInt J Pharm2011421223023621983091
- ShahzadiIMasoodMIChowdharyFMicroemulsion formulation for topical delivery of miconazole nitrateInt J Pharm Sci Rev Res20142463036
- EllepolaANSamaranayakeLPAntimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosisDent Update200027416517411218451
- PeiraECarlottiMETrottaCPositively charged microemulsions for topical applicationInt J Pharm20083461–211912317618070
- SabriLASulaymanHTKhalilYIAn investigation release and rheological properties of miconazole nitrate from EmulgelIraqi J Pharm Sci20091822631
- CerdeiraAMMazzottiMGanderBMiconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stabilityInt J Pharm201039621021820600732
- JacobsenJBjerregaardSPedersenMCyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity-drug supersaturation, toxicity on TR146 cells and release from a delivery systemEur J Pharm Biopharm199948321722410612032
- LevyMYPolacheckIBarenholzYEfficacy evaluation of a novel submicron miconazole emulsion in a murine cryptococcosis modelPharm Res19951222232307784337
- MüllerRHShegokarRKeckCM20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applicationsCurr Drug Discov Technol20118320722721291409
- TenjarlaSPuranajotiPKasinaRPreparation, characterization, and evaluation of miconazole–cyclodextrin complexes for improved oral and topical deliveryJ Pharm Sci19988744254299548893
- HostetlerJSHansonLHStevensDAEffect of cyclodextrin on the pharmacology of antifungal oral azolesAntimicrob Agents Chemother19923624774801605615
- MullerRHMaderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
- BoltriLCanalTEspositoPLipid nanoparticles: evaluation of some critical formulation parametersProc Int Symp Control Release Bioact Mater19932020346347
- YadavPSoniGMahorASolid lipid nanoparticles: an effective and promising drug delivery system-A reviewInt J Pharm Sci Res2014541152
- HosnyKMAljaeidBMSildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunctionExpert Opin Drug Deliv20141171015102224746063
- MunsterUNakamuraCHaberlandARU 58841-myristate-prodrug development for topical treatment of acne and androgenetic alopeciaPharmazie200560181215700772
- WissingSAKayserOMüllerRHSolid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev20045691257127215109768
- CavalliRGascoMRChetoniPSolid lipid nanoparticles (SLN) as ocular delivery system for tobramycinInt J Pharm20022381–224124511996827
- SinhaVRSrivastavaSGoelHSolid lipid nanoparticles (SLN’S)-trends and implications in drug targetingInt J Adv Pharm Sci201013212238
- EkambaramPSathaliAAHPriyankaKSolid lipid nanoparticles: a reviewSci Rev Chem Commun20122180102
- KambleMSVaidyaKKBhosaleAVSolid lipid nanoparticles and nanostructured lipid carriers-an overviewInt J Pharm Chem Biol Sci201224681691
- ElshafeeyABendasEMohamedOIntranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbitsAAPS PharmSciTech200910236136719333762
- YangZGaoSWangJEnhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanismsDrug Metab Dispos201139101866187221757611
- SannaVCariaGMarianiAEffect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of econazole nitratePowder Technol201020113236
- TanvirSQiaoLSurface tension of nanofluid-type fuels containing suspended nanomaterialsNanoscale Res Lett20127122622513039
- UnerMWissingSAYenerGInfluence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulationsPharmazie200459433133215125588
- DoijadRCManviFVGodhwaniDMFormulation and targeting efficiency of cisplatin engineered solid lipid nanoparticlesIndian J Pharm Sci200870220320720046713